Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis
- Autores
- Yuen, Kevin C. J.; Johannsson, Gudmundur; Ho, Ken K. Y.; Miller, Bradley S.; Bergadá, Ignacio; Rogol, Alan D.
- Año de publicación
- 2023
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficiencies. Although diminished height velocity and short stature are useful and important clinical markers to consider testing for GHD in children, the signs and symptoms of GHD are not always so apparent in adults. Quality of life and metabolic health are often impacted in patients with GHD; thus, making an accurate diagnosis is important so that appropriate growth hormone (GH) replacement therapy can be offered to these patients. Screening and testing for GHD require sound clinical judgment that follows after obtaining a complete medical history of patients with a hypothalamic–pituitary disorder and a thorough physical examination with specific features for each period of life, while targeted biochemical testing and imaging are required to confirm the diagnosis. Random measurements of serum GH levels are not recommended to screen for GHD (except in neonates) as endogenous GH secretion is episodic and pulsatile throughout the lifespan. One or more GH stimulation tests may be required, but existing methods of testing might be inaccurate, difficult to perform, and can be imprecise. Furthermore, there are multiple caveats when interpreting test results including individual patient factors, differences in peak GH cut-offs (by age and test), testing time points, and heterogeneity of GH and insulin-like growth factor 1 assays. In this article, we provide a global overview of the accuracy and cut-offs for diagnosis of GHD in children and adults and discuss the caveats in conducting and interpreting these tests.
Fil: Yuen, Kevin C. J.. University of Arizona; Estados Unidos
Fil: Johannsson, Gudmundur. University of Gothenburg; Suecia
Fil: Ho, Ken K. Y.. University of New South Wales; Australia
Fil: Miller, Bradley S.. University of Minnesota; Estados Unidos
Fil: Bergadá, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina
Fil: Rogol, Alan D.. University of Virginia; Estados Unidos - Materia
-
Growth hormone deficiency
Children
Adult - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/256060
Ver los metadatos del registro completo
| id |
CONICETDig_88233d6aeb8cca8a1bc38bd56b34778d |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/256060 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosisYuen, Kevin C. J.Johannsson, GudmundurHo, Ken K. Y.Miller, Bradley S.Bergadá, IgnacioRogol, Alan D.Growth hormone deficiencyChildrenAdulthttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficiencies. Although diminished height velocity and short stature are useful and important clinical markers to consider testing for GHD in children, the signs and symptoms of GHD are not always so apparent in adults. Quality of life and metabolic health are often impacted in patients with GHD; thus, making an accurate diagnosis is important so that appropriate growth hormone (GH) replacement therapy can be offered to these patients. Screening and testing for GHD require sound clinical judgment that follows after obtaining a complete medical history of patients with a hypothalamic–pituitary disorder and a thorough physical examination with specific features for each period of life, while targeted biochemical testing and imaging are required to confirm the diagnosis. Random measurements of serum GH levels are not recommended to screen for GHD (except in neonates) as endogenous GH secretion is episodic and pulsatile throughout the lifespan. One or more GH stimulation tests may be required, but existing methods of testing might be inaccurate, difficult to perform, and can be imprecise. Furthermore, there are multiple caveats when interpreting test results including individual patient factors, differences in peak GH cut-offs (by age and test), testing time points, and heterogeneity of GH and insulin-like growth factor 1 assays. In this article, we provide a global overview of the accuracy and cut-offs for diagnosis of GHD in children and adults and discuss the caveats in conducting and interpreting these tests.Fil: Yuen, Kevin C. J.. University of Arizona; Estados UnidosFil: Johannsson, Gudmundur. University of Gothenburg; SueciaFil: Ho, Ken K. Y.. University of New South Wales; AustraliaFil: Miller, Bradley S.. University of Minnesota; Estados UnidosFil: Bergadá, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Rogol, Alan D.. University of Virginia; Estados UnidosBioScientifica2023-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/256060Yuen, Kevin C. J.; Johannsson, Gudmundur; Ho, Ken K. Y.; Miller, Bradley S.; Bergadá, Ignacio; et al.; Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis; BioScientifica; Endocrine Connections; 12; 7; 4-2023; 1-192049-3614CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://ec.bioscientifica.com/view/journals/ec/12/7/EC-22-0504.xmlinfo:eu-repo/semantics/altIdentifier/doi/10.1530/EC-22-0504info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-11-26T08:57:27Zoai:ri.conicet.gov.ar:11336/256060instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-11-26 08:57:27.89CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis |
| title |
Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis |
| spellingShingle |
Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis Yuen, Kevin C. J. Growth hormone deficiency Children Adult |
| title_short |
Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis |
| title_full |
Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis |
| title_fullStr |
Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis |
| title_full_unstemmed |
Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis |
| title_sort |
Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis |
| dc.creator.none.fl_str_mv |
Yuen, Kevin C. J. Johannsson, Gudmundur Ho, Ken K. Y. Miller, Bradley S. Bergadá, Ignacio Rogol, Alan D. |
| author |
Yuen, Kevin C. J. |
| author_facet |
Yuen, Kevin C. J. Johannsson, Gudmundur Ho, Ken K. Y. Miller, Bradley S. Bergadá, Ignacio Rogol, Alan D. |
| author_role |
author |
| author2 |
Johannsson, Gudmundur Ho, Ken K. Y. Miller, Bradley S. Bergadá, Ignacio Rogol, Alan D. |
| author2_role |
author author author author author |
| dc.subject.none.fl_str_mv |
Growth hormone deficiency Children Adult |
| topic |
Growth hormone deficiency Children Adult |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficiencies. Although diminished height velocity and short stature are useful and important clinical markers to consider testing for GHD in children, the signs and symptoms of GHD are not always so apparent in adults. Quality of life and metabolic health are often impacted in patients with GHD; thus, making an accurate diagnosis is important so that appropriate growth hormone (GH) replacement therapy can be offered to these patients. Screening and testing for GHD require sound clinical judgment that follows after obtaining a complete medical history of patients with a hypothalamic–pituitary disorder and a thorough physical examination with specific features for each period of life, while targeted biochemical testing and imaging are required to confirm the diagnosis. Random measurements of serum GH levels are not recommended to screen for GHD (except in neonates) as endogenous GH secretion is episodic and pulsatile throughout the lifespan. One or more GH stimulation tests may be required, but existing methods of testing might be inaccurate, difficult to perform, and can be imprecise. Furthermore, there are multiple caveats when interpreting test results including individual patient factors, differences in peak GH cut-offs (by age and test), testing time points, and heterogeneity of GH and insulin-like growth factor 1 assays. In this article, we provide a global overview of the accuracy and cut-offs for diagnosis of GHD in children and adults and discuss the caveats in conducting and interpreting these tests. Fil: Yuen, Kevin C. J.. University of Arizona; Estados Unidos Fil: Johannsson, Gudmundur. University of Gothenburg; Suecia Fil: Ho, Ken K. Y.. University of New South Wales; Australia Fil: Miller, Bradley S.. University of Minnesota; Estados Unidos Fil: Bergadá, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina Fil: Rogol, Alan D.. University of Virginia; Estados Unidos |
| description |
Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficiencies. Although diminished height velocity and short stature are useful and important clinical markers to consider testing for GHD in children, the signs and symptoms of GHD are not always so apparent in adults. Quality of life and metabolic health are often impacted in patients with GHD; thus, making an accurate diagnosis is important so that appropriate growth hormone (GH) replacement therapy can be offered to these patients. Screening and testing for GHD require sound clinical judgment that follows after obtaining a complete medical history of patients with a hypothalamic–pituitary disorder and a thorough physical examination with specific features for each period of life, while targeted biochemical testing and imaging are required to confirm the diagnosis. Random measurements of serum GH levels are not recommended to screen for GHD (except in neonates) as endogenous GH secretion is episodic and pulsatile throughout the lifespan. One or more GH stimulation tests may be required, but existing methods of testing might be inaccurate, difficult to perform, and can be imprecise. Furthermore, there are multiple caveats when interpreting test results including individual patient factors, differences in peak GH cut-offs (by age and test), testing time points, and heterogeneity of GH and insulin-like growth factor 1 assays. In this article, we provide a global overview of the accuracy and cut-offs for diagnosis of GHD in children and adults and discuss the caveats in conducting and interpreting these tests. |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2023-04 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/256060 Yuen, Kevin C. J.; Johannsson, Gudmundur; Ho, Ken K. Y.; Miller, Bradley S.; Bergadá, Ignacio; et al.; Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis; BioScientifica; Endocrine Connections; 12; 7; 4-2023; 1-19 2049-3614 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/256060 |
| identifier_str_mv |
Yuen, Kevin C. J.; Johannsson, Gudmundur; Ho, Ken K. Y.; Miller, Bradley S.; Bergadá, Ignacio; et al.; Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis; BioScientifica; Endocrine Connections; 12; 7; 4-2023; 1-19 2049-3614 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://ec.bioscientifica.com/view/journals/ec/12/7/EC-22-0504.xml info:eu-repo/semantics/altIdentifier/doi/10.1530/EC-22-0504 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
BioScientifica |
| publisher.none.fl_str_mv |
BioScientifica |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1849873198715240448 |
| score |
13.011256 |